Therapeutic Class

Dyslipidaemic Agents


Corpid used complementary to diet to reduce total cholesterol, LDL- cholesterol, apo- B and triglycerides in humans increased cholesterol/ blood with primary (heterozygous type with or without the family) and lipid disturbances / blood mixture (the Fredrickson type II a and II b). Atorvastatin is also indicated complementary to diet to treat the increased concentrations of triglyceride/ serum (Fredrickson Type IV). As indicated for the treatment of beta - lipoprotein/ blood disorder (Fredrickson Type III) that do not meet full nutrition, also used to lower cholesterol/ blood homozygous familial character, such as supplements for other drugs to reduce lipid group/ blood or when the drug was not effective.

Chemical Composition

Atorvastatin Calcium Equivalent to Atorvastatin 10 mg


1 x 10's/ Box

Dosage & Administration

The starting dose is 10mg daily. Daily dose range is 10- 80mg, used 1time / day. Infants after breastfeeding: drug information for this object has not been established.


Hypersensitivity to drug ingredients. Advanced liver disease or when there is increased transaminase / serum persistent , unexplainable and triple the highest normal level.

Side Effects

Atorvastatin tolerated. These adverse reactions may experience constipation, heartburn, anorexia, abdominal pain, headache, nausea, muscle pain, diarrhea, fatigue, insomnia. *Inform to physician if any unwanted effects occur during drug*

Drug Interaction

Antacid: When atorvastatin combines with an antacid suspension, the plasma concentrations of atorvastatin decreased approximately 35%. Colestipol: Coordinate colestipol with atorvastatin reduces the concentration of atorvastatin / plasma is about 25%. Digoxin: When multiple doses of atorvastatin is taken with digoxin, the stable digoxin concentration / plasma will be increased 20% . Erythromycin: In healthy people, oral erythromycin with atorvastatin will make the concentrations of atorvastatin/ plasma increased 40%. Oral contraceptives: the combination of atorvastatin with oral contraceptives, the value of the area under the curve (AUC) of norethindrone and ethinyl estradiol will increase in the order of 30% and 20%